NCT06277830 - Physical Activity Monitoring in Myasthenia Gravis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 14, 2024

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions

Myasthenia Gravis

Interventions

DEVICE

Wearable sensor

Participants will wear a pendant sensor for 7 days and then participate in an on-site examination with using a tablet designed to evaluate weakness in MG.

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston